Intraventricular rifampicin in severe tuberculous meningo-encephalitis

Eur Respir J. 1992 Jul;5(7):891-3.

Abstract

We present a patient acutely ill from severe tuberculous meningo-encephalitis, in whom acute hepatic and renal failure, due to intercurrent septic shock, precluded the administration of full systemic dosage of antituberculous drugs. Daily direct intraventricular administration of 5 mg rifampicin, via a subcutaneous Ommaya reservoir connected to a catheter placed in the right lateral cerebral ventricle, resulted in rapid improvement without neurological sequelae. Intraventricular rifampicin administration for 50 consecutive days was well-tolerated without local or systemic side-effects. In well-selected patients with severe tuberculous meningo-encephalitis, intraventricular rifampicin may safely and highly effectively be added to systemic antituberculous therapy.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / complications
  • Catheters, Indwelling
  • Cerebral Ventricles
  • Humans
  • Infusion Pumps, Implantable
  • Liver Diseases / complications
  • Male
  • Meningoencephalitis / complications
  • Meningoencephalitis / drug therapy*
  • Middle Aged
  • Rifampin / administration & dosage*
  • Rifampin / therapeutic use
  • Shock, Septic / complications
  • Tuberculosis, Meningeal / complications
  • Tuberculosis, Meningeal / drug therapy*

Substances

  • Rifampin